Intrathecal morphine with bupivacaine

ApprovedSmall molecule

Intrathecal morphine with bupivacaine is one of 45 small molecule programs targeting Cesarean Section. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cesarean SectionActive, not recruiting

Cesarean SectionApproved

Active, not recruiting

Competition

Competitive Landscape

230 competitors in Cesarean Section

#DrugCompanyPhaseTrials

Intrathecal morphine with bupivacaine

MMakerere University

Approved

1 2

Marcaine

IInnocoll

Preclinical

21 3

Pitocin

RRetrophin

Preclinical

16 4

Naropin

FFresenius Kabi Oncology Ltd.

Preclinical

12 5

Neo-Synephrine

EExela Pharma Sciences, LLC.

Preclinical

11 6

Dynastat

Pfizer

Preclinical

1 7

Duragesic

CCephalon

Preclinical

6 8

Catapres

Boehringer Ingelheim

Preclinical

4 9

Versed

CConrado Roberto Hoffmann Filho

Preclinical

4 10

Nubain

AAultman Health Foundation

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Post-ApprovalNot yet recruiting

Cesarean Section

NCT07094802

Clinical

Trials by Indication[1]

Cesarean Section1 trial

Comparison of Intrathecal Bupivacaine With and Without Morphine for Post-operative Analgesia in Parturients Undergoing Elective Cesarean Section: A Randomized Controlled Trial

Not yet recruiting·TTribhuvan University Teaching Hospital, Institute Of Medicine.·Phase 4·NCT07094802·92 enrolled

Bupivacaine1 trial

Labour Analgesia; Comparing a Combinations of Either Fentanyl or Bupivacaine With Intrathecal Morphine

Completed·MMakerere University·N/A·NCT02498171·138 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Intrathecal morphine with bupivacaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intrathecal morphine with bupivacaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intrathecal morphine with bupivacaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Makerere University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: MMakerere University

Intrathecal morphine with bupivacaine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

Cesarean Section1 trial

Bupivacaine1 trial

References

Drug Info

Quick Facts

Related News